Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
Figure 4
Urine protein excretion in diabetic Ren-2 rats treated with vehicle, vandetanib, or vandetanib + L-NAME for 24 days. versus vehicle and versus either vehicle or vandetanib.